Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases

Overview

Journal Transl Vis Sci Technol

Specialties Biomedical Engineering
Ophthalmology

Date 2021 Jun 10

PMID 34110387

Citations 6

Authors

Lukas Goerdt

Lydia Sauer

Alexandra S Vitale

Natalie K Modersitzki

Monika Fleckenstein

Paul S Bernstein

Affiliations

Soon will be listed here.

Abstract

Purpose: Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a non-invasive imaging modality to investigate the human retina. This study compares FLIO lifetimes in different degenerative retinal diseases.

Methods: Included were eyes with retinal pigment epithelium (RPE) and/or photoreceptor atrophy due to Stargardt disease (n = 66), pattern dystrophy (n = 18), macular telangiectasia type 2 (n = 49), retinitis pigmentosa (n = 28), choroideremia (n = 26), and geographic atrophy (n = 32) in age-related macular degeneration, as well as 37 eyes of 37 age-matched healthy controls. Subjects received Heidelberg Engineering FLIO, autofluorescence intensity, and optical coherence tomography imaging. Amplitude-weighted mean FLIO lifetimes (τm) were calculated and analyzed.

Results: Retinal FLIO lifetimes show significant differences depending on the disease. Atrophic areas in geographic atrophy and choroideremia showed longest mean FLIO lifetimes. τm values within areas of RPE and outer nuclear layer atrophy were significantly longer than within areas with preserved outer nuclear layer (P < 0.001) or non-atrophic areas (P < 0.001).

Conclusions: FLIO is able to contribute additional information regarding differences in chronic degenerative retinal diseases. Although it cannot replace conventional autofluorescence imaging, FLIO adds to the knowledge in these diseases and may help with the correct differentiation between them. This may lead to a more in-depth understanding of the pathomechanisms related to atrophy and types of progression.

Translational Relevance: Differences between atrophic retinal diseases highlighted by FLIO may indicate separate pathomechanisms leading to atrophy and disease progression.

Citing Articles

From Cellular to Metabolic: Advances in Imaging of Inherited Retinal Diseases.

Parameswarappa D, Kulkarni A, Sahoo N, Padhy S, Singh S, Heon E Diagnostics (Basel). 2025; 15(1.

PMID: 39795556 PMC: 11720060. DOI: 10.3390/diagnostics15010028.

Hyperautofluorescent material inside areas of macular atrophy may reveal non-lipofuscin fluorophores in late stage AMD.

Tarhan M, Meller D, Hammer M Acta Ophthalmol. 2024; 103(1):e66-e75.

PMID: 39177106 PMC: 11704839. DOI: 10.1111/aos.16752.

Multispectral label-free cellular imaging of human retinal pigment epithelium using adaptive optics fluorescence lifetime ophthalmoscopy improves feasibility for low emission analysis and increases sensitivity for detecting changes with age and....

Kunala K, Tang J, Parkins K, Hunter J J Biomed Opt. 2024; 29(Suppl 2):S22707.

PMID: 38962492 PMC: 11221116. DOI: 10.1117/1.JBO.29.S2.S22707.

Near Infrared Autofluorescence Lifetime Imaging of Human Retinal Pigment Epithelium Using Adaptive Optics Scanning Light Ophthalmoscopy.

Kunala K, Tang J, Bowles Johnson K, Huynh K, Parkins K, Kim H Invest Ophthalmol Vis Sci. 2024; 65(5):27.

PMID: 38758638 PMC: 11107951. DOI: 10.1167/iovs.65.5.27.

Curcio C, Kar D, Owsley C, Sloan K, Ach T Invest Ophthalmol Vis Sci. 2024; 65(3):4.

PMID: 38466281 PMC: 10916886. DOI: 10.1167/iovs.65.3.4.

References

Sunness J . The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999; 5:25. View

Rangaswamy N, Patel H, Locke K, Hood D, Birch D . A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2010; 51(8):4213-9. PMC: 2910646. DOI: 10.1167/iovs.09-4945. View

Sallo F, Leung I, Mathenge W, Kyari F, Kuper H, Gilbert C . The prevalence of type 2 idiopathic macular telangiectasia in two African populations. Ophthalmic Epidemiol. 2012; 19(4):185-9. DOI: 10.3109/09286586.2011.638744. View

Cideciyan A, Aleman T, Swider M, Schwartz S, Steinberg J, Brucker A . Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004; 13(5):525-34. DOI: 10.1093/hmg/ddh048. View

Hamel C . Retinitis pigmentosa. Orphanet J Rare Dis. 2006; 1:40. PMC: 1621055. DOI: 10.1186/1750-1172-1-40. View

Sauer L, Andersen K, Dysli C, Zinkernagel M, Bernstein P, Hammer M . Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. J Biomed Opt. 2018; 23(9):1-20. PMC: 8357196. DOI: 10.1117/1.JBO.23.9.091415. View

MacDonald I, Russell L, Chan C . Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol. 2009; 54(3):401-7. PMC: 2679958. DOI: 10.1016/j.survophthal.2009.02.008. View

Zanzottera E, Ach T, Huisingh C, Messinger J, Freund K, Curcio C . VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2016; 36 Suppl 1:S26-S39. PMC: 5542007. DOI: 10.1097/IAE.0000000000001330. View

Vitale A, Sauer L, Modersitzki N, Bernstein P . Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia. Transl Vis Sci Technol. 2020; 9(10):33. PMC: 7533737. DOI: 10.1167/tvst.9.10.33. View

10.

Solberg Y, Dysli C, Escher P, Berger L, Wolf S, Zinkernagel M . Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration. Ophthalmologica. 2019; 243(3):195-206. DOI: 10.1159/000503567. View

11.

Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez M, Sanchez-Bolivar N, Zurita O, Gimenez A . A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice. PLoS One. 2016; 11(4):e0151943. PMC: 4829155. DOI: 10.1371/journal.pone.0151943. View

12.

Seabra M, Brown M, Slaughter C, Sudhof T, Goldstein J . Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product. Cell. 1992; 70(6):1049-57. DOI: 10.1016/0092-8674(92)90253-9. View

13.

Pfau M, von der Emde L, Dysli C, Thiele S, Moller P, Lindner M . Light Sensitivity Within Areas of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2019; 60(12):3992-4001. DOI: 10.1167/iovs.19-27178. View

14.

Sauer L, Vitale A, Milliken C, Modersitzki N, Blount J, Bernstein P . Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender. Transl Vis Sci Technol. 2020; 9(9):2. PMC: 7442880. DOI: 10.1167/tvst.9.9.2. View

15.

Klemm M, Schweitzer D, Peters S, Sauer L, Hammer M, Haueisen J . FLIMX: A Software Package to Determine and Analyze the Fluorescence Lifetime in Time-Resolved Fluorescence Data from the Human Eye. PLoS One. 2015; 10(7):e0131640. PMC: 4507995. DOI: 10.1371/journal.pone.0131640. View

16.

GASS J, Oyakawa R . Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982; 100(5):769-80. DOI: 10.1001/archopht.1982.01030030773010. View

17.

Ozkaya A, Garip R, Nur Tarakcioglu H, Alkin Z, Taskapili M . Clinical and imaging findings of pattern dystrophy subtypes; Diagnostic errors and unnecessary treatment in clinical practice. J Fr Ophtalmol. 2017; 41(1):21-29. DOI: 10.1016/j.jfo.2017.06.009. View

18.

Farjo R, Naash M . The role of Rds in outer segment morphogenesis and human retinal disease. Ophthalmic Genet. 2006; 27(4):117-22. DOI: 10.1080/13816810600976806. View

19.

Dysli C, Wolf S, Hatz K, Zinkernagel M . Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression. Invest Ophthalmol Vis Sci. 2016; 57(3):832-41. DOI: 10.1167/iovs.15-18033. View

20.

Lindner M, Boker A, Mauschitz M, Gobel A, Fimmers R, Brinkmann C . Directional Kinetics of Geographic Atrophy Progression in Age-Related Macular Degeneration with Foveal Sparing. Ophthalmology. 2015; 122(7):1356-65. DOI: 10.1016/j.ophtha.2015.03.027. View